Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (MgNLC); a Prospective, Randomized, Double Blind, Placebo Controlled Clinical Trial.

NCT01709968 is registered in ClinicalTrials.gov with Uzi Milman as lead sponsor.

NCT NCT01709968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01709968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnesium Oxide Monohydrate for Nocturnal Leg Cramps (MgNLC); a Prospective, Randomized, Double Blind, Placebo Controlled Clinical Trial.
Lead sponsor
Uzi Milman
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2013
Completion date
April 30, 2014
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nocturnal leg cramps, quality of life